Palvella Therapeutics, Inc. (PVLA) Q2 FY25 Earnings Call

Q2 FY25 results, source: company transcript and SEC filings
QuarterQ2 FY25
Call date2025-08-14
Length51 minutes
EPS$-0.86
EPS consensus$-0.78

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26

All PVLA earnings ยท Back to PVLA overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.